BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14646690)

  • 1. Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.
    Yasar U; Bennet AM; Eliasson E; Lundgren S; Wiman B; De Faire U; Rane A
    Pharmacogenetics; 2003 Dec; 13(12):715-20. PubMed ID: 14646690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
    Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
    Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
    Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9.
    Visser LE; van Schaik RH; Jan Danser AH; Hofman A; Witteman JC; van Duijn CM; Uitterlinden AG; Pols HA; Stricker BH
    Pharmacogenet Genomics; 2007 Jul; 17(7):473-9. PubMed ID: 17558303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort.
    Haschke-Becher E; Kirchheiner J; Trummer O; Grünbacher G; Kainz A; Boehm BO; März W; Renner W
    Pharmacogenomics; 2010 Oct; 11(10):1359-65. PubMed ID: 21047199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.
    Chang TK; Yu L; Goldstein JA; Waxman DJ
    Pharmacogenetics; 1997 Jun; 7(3):211-21. PubMed ID: 9241661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
    Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
    Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
    Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variance in CYP2C8 and increased risk of myocardial infarction.
    Rodenburg EM; Visser LE; Danser AH; Hofman A; van Noord C; Witteman JC; Uitterlinden AG; Stricker BH
    Pharmacogenet Genomics; 2010 Jul; 20(7):426-34. PubMed ID: 20436375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes.
    Lundblad MS; Stark K; Eliasson E; Oliw E; Rane A
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1052-7. PubMed ID: 15652503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Polymorphisms of Cytochrome p450 (2C9) Enzyme in Patients with Type 2 Diabetes Mellitus in Turkmen and Fars Ethnic Groups.
    Rabiee M; Marjani A; Khajeniazi S; Mojerloo M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):653-661. PubMed ID: 30129421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population.
    Mehri S; Baudin B; Mahjoub S; Zaroui A; Bénéteau-Burnat B; Mechmeche R; Hammami M; Ben Arab S
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):85-91. PubMed ID: 20059382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
    Rifkind AB; Lee C; Chang TK; Waxman DJ
    Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.
    Yasar U; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjöqvist F
    Biochem Biophys Res Commun; 1999 Jan; 254(3):628-31. PubMed ID: 9920790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
    Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
    Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.